Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer.

Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer.

Item
http://www.wikidata.org/entity/Q33398185
Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysisProgression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma.Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report.Emerging new therapeutic applications of capecitabine as a first-line chemotherapeutic agent in the management of advanced carcinomas other than colorectal carcinoma.Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study.Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review.Head and neck cancer in Hong Kong.Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update.
P2860

Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer.

Item
http://www.wikidata.org/entity/Q33398185
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phase II trial of capecitabine ...... astatic nasopharyngeal cancer.
@ast
Phase II trial of capecitabine ...... astatic nasopharyngeal cancer.
@en
type
label
Phase II trial of capecitabine ...... astatic nasopharyngeal cancer.
@ast
Phase II trial of capecitabine ...... astatic nasopharyngeal cancer.
@en
prefLabel
Phase II trial of capecitabine ...... astatic nasopharyngeal cancer.
@ast
Phase II trial of capecitabine ...... astatic nasopharyngeal cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Phase II trial of capecitabine ...... astatic nasopharyngeal cancer.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921